Family summary
Historical shortage references are available across related Enoxaparin sodium presentations from multiple manufacturers.
- 0 current shortage context pages.
- 10 historical shortage context pages.
- 2 manufacturers represented.
Enoxaparin sodium - Drug Shortage Information
Public shortage context is available across 10 visible exact NDC pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
enoxaparin sodium 40 mg / .4mL Injection 0.4 mL (Lovenox) - NDC 00075-0620-40Sanofi-Aventis U.S. LLC | 10 Cello Packenoxaparin sodium 60 mg / .6mL Injection 0.6 mL (Lovenox) - NDC 00075-0621-60Sanofi-Aventis U.S. LLC | 10 Cello Packenoxaparin sodium 80 mg / .8mL Injection 0.8 mL (Lovenox) - NDC 00075-0622-80Sanofi-Aventis U.S. LLC | 10 Cello Packenoxaparin sodium 100 mg / mL Injection 1 mL (Lovenox) - NDC 00075-0623-00Sanofi-Aventis U.S. LLC | 10 Cello Packenoxaparin sodium 30 mg / .3mL Injection 0.3 mL (Lovenox) - NDC 00075-0624-30Sanofi-Aventis U.S. LLC | 10 Cello Pack
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.